swoosh

Need more assay performance in less time?

Get there in 3 swift steps with Sword.

See How

Sword enables you to get more out of your existing assays to answer critical development questions faster. Through our Sword SWIFT program, we will:

prove performance boost

Prove Performance Boost

Sword will optimize your target ELISA assay to verify our ability to improve:

  • Sensitivity by 10 – 30 fold
  • LLOQ by 5 – 10 fold
  • Accuracy to 80 – 120%

6 Days

icon optimize sample

Optimize for Your Sample

We’ll rapidly configure our chemistries to your specific matrix needs to:

  • Reduce matrix effects
  • Reduce sample size
  • Reduce assay time

14 Days

test transfer reliability

Test or Transfer Reliably

Our platform ensures assay robustness and reliability whether you choose to:

  • Have Sword transfer and verify assay performance on-site
  • Utilize Sword’s testing services

Try Sword Swift

Explore Sword Assays for:

Speed decision-making with Sword SWIFT.

Precision medicine is innovating at a rapid pace. Sword’s process ensures you get reproducible, robust data, faster, to make efficient ‘go’ / ‘no go’ decisions that save development time and keep you ahead.

See how we prove it

Deploy our platform in your lab with Sword ON-SITE.

Sword experts will certify your lab team to use our technology and processes at your site, with ongoing remote support.

Learn more

 

challenge

Take the Sword SWIFT Challenge

Put us to the test: we will conduct a performance assessment of your first target assay free of charge.

Take the challenge

Featured Assay

Looking to Optimize Your Assays for ADA Analysis?

Sword Bio has optimized a number of proprietary assays to support the analysis of anti-drug antibodies (ADAs) with significantly improved sensitivity, precision, and performance.

Learn How

Press Release

BioAgilytix Partners with Sword Bio to Provide Superior Immunoassays

The companies will collaborate to meet ever-growing customer needs to further enhance the performance of immunoassays used for biomarkers, immunogenicity, and pharmacokinetics (PK).

Read More